Sort

Search

28/08/2023 Tuberculous arthritis of native joints - a systematic review and European Bone and Joint Infection Society workgroup report.
Marais LC, Nieuwoudt L, Nansook A, Menon A, Benito N. Tuberculous arthritis of native joints - a systematic review and European Bone and Joint Infection Society workgroup report.. Journal Of Bone And Joint Infection. 2023; 8(4)DOI:10.5194/jbji-8-189-2023. PMID:37780528. IF:(Q/D).
26/08/2023 Multidisciplinary consensus document on the management of massive haemorrhage. First update 2023 (document HEMOMAS-II).
Llau JV, Aldecoa C, Guasch E, Marco P, Marcos-Neira P, Paniagua P, Páramo JA, Quintana M, Rodríguez-Martorell FJ, Serrano A. Multidisciplinary consensus document on the management of massive haemorrhage. First update 2023 (document HEMOMAS-II).. Revista Espanola De Anestesiologia Y Reanimacion. 2023; 70(7)DOI:10.1016/j.redare.2023.08.001. PMID:37640281. IF:(Q/D).
25/08/2023 2023 ESC Guidelines for the management of endocarditis
Delgado, V, Marsan, N, de Waha, S, Bonaros, N, Brida, M, Burri, H, Caselli, S, Doenst, T, Ederhy, S, Erba, PA, Foldager, D, Fosbol, EL, Kovac, J, Mestres, CA, Miller, O, Miro, JM, Pazdernik, M, Pizzi, MN, Quintana, E, Rasmussen, TB, Ristic, AD, Rodés-Cabau, J, Sionis, A, Zühlke, LJ, Borger, MA, ESC Sci Document Grp. 2023 ESC Guidelines for the management of endocarditis. EUROPEAN HEART JOURNAL. 2023; 44(39)DOI:10.1093/eurheartj/ehad193. PMID:37622656. IF:38.100(Q1/1D).
24/08/2023 Factors associated with the need of parenteral nutrition in critically ill patients after the initiation of enteral nutrition therapy.
Lopez-Delgado JC, Servia-Goixart L, Grau-Carmona T, Bordeje-Laguna L, Portugal-Rodriguez E, Lorencio-Cardenas C, Vera-Artazcoz P, Macaya-Redin L, Martinez-Carmona JF, Marin Corral J, Flordelís-Lasierra JL, Seron-Arbeloa C, Alcazar-Espin MLN, Navas-Moya E, Aldunate-Calvo S, Nieto Martino B, Martinez de Lagran I. Factors associated with the need of parenteral nutrition in critically ill patients after the initiation of enteral nutrition therapy.. Frontiers in Nutrition. 2023; 10DOI:10.3389/fnut.2023.1250305. PMID:37693244. IF:4.000(Q2/3D).
23/08/2023 Ixekizumab for the treatment of moderate-to-severe plaque psoriasis: the first septennium
Carmona-Rocha, E, Puig, L. Ixekizumab for the treatment of moderate-to-severe plaque psoriasis: the first septennium. Immunotherapy. 2023; 15(15)DOI:10.2217/imt-2023-0013. PMID:37609785. IF:2.700(Q3/7D).
23/08/2023 Assessing the value of moderate-to-severe atopic dermatitis treatment using multi-criteria decision analysis (MCDA)
Pereyra-Rodríguez J.J., Poveda J.L., Rivero A., Serra-Baldrich E., Silvestre J.F., Armario-Hita J.C., Calleja M.Á., Carrascosa J.M., Flórez Á., Herranz P., Comellas M., Ortiz de Frutos F.J.. Assessing the value of moderate-to-severe atopic dermatitis treatment using multi-criteria decision analysis (MCDA). JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2023; DOI:10.1111/jdv.19432. PMID:37594914. IF:8.500(Q1/1D).
23/08/2023 Women, lipids, and atherosclerotic cardiovascular disease: a call to action from the European Atherosclerosis Society
van Lennep, JER, Tokgozoglu, LS, Badimon, L, Dumanski, SM, Gulati, M, Hess, CN, Holven, KB, Kavousi, M, Kayikcioglu, M, Lutgens, E, Michos, ED, Prescott, E, Stock, JK, Tybjaerg-Hansen, A, Wermer, MJH, Benn, M. Women, lipids, and atherosclerotic cardiovascular disease: a call to action from the European Atherosclerosis Society. EUROPEAN HEART JOURNAL. 2023; 44(39)DOI:10.1093/eurheartj/ehad472. PMID:37611089. IF:38.100(Q1/1D).
22/08/2023 Arterial tortuosity syndrome: Phenotypic features and cardiovascular manifestations in 4 newly identified patients
Esmel-Vilomara R., Valenzuela I., Riaza L., Rodríguez-Santiago B., Rosés-Noguer F., Boronat S., Sabaté-Rotés A.. Arterial tortuosity syndrome: Phenotypic features and cardiovascular manifestations in 4 newly identified patients. European Journal of Medical Genetics. 2023; 66(9)DOI:10.1016/j.ejmg.2023.104823. PMID:37619836. IF:1.600(Q4/8D).